Dynamic contrast enhanced MRI in prostate cancer

European Journal of Radiology

Volumn 63, Issue 3, 2007, Pages 335-350

  Alonzi, Roberto ^a   Padhani, Anwar R ^a,b   Allen, Clare ^c  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

^b SYNARC INC   (United States)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Androgen deprivation; Angiogenesis; Diffusion MRI; Dynamic MRI; Prostate cancer; Radiotherapy

Indexed keywords

ANGIOGRAPHY; DATA ACQUISITION; ONCOLOGY; RADIOTHERAPY;

ANDROGEN DEPRIVATION; DIFFUSION MRI; DYNAMIC MRI; PROSTATE CANCERS;

MAGNETIC RESONANCE IMAGING;

ANDROGEN; GADOLINIUM CHELATE; PROSTATE SPECIFIC ANTIGEN;

ANALYTIC METHOD; ANGIOGENESIS; ARTICLE; BIOLOGY; BLOOD LEVEL; BLOOD VESSEL PERMEABILITY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CARCINOGENESIS; CONTRAST ENHANCEMENT; CRYOSURGERY; DATA ANALYSIS; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; EXTRACELLULAR SPACE; HIGH INTENSITY FOCUSED ULTRASOUND; HORMONE DEFICIENCY; HUMAN; INTERMETHOD COMPARISON; LASER SURGERY; METASTASIS; MICROVASCULATURE; MICROWAVE THERAPY; MOLECULAR WEIGHT; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATITIS; TISSUE PERFUSION; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VASCULARIZATION; UNCERTAINTY; VALIDATION PROCESS;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 34548265284     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2007.06.028     Document Type: Article

References (51)

1. McNeal J.E. The prostate gland morphology and pathobiology. Monogr Urol (1983) 13-45
2. Jackson M.W., Bentel J.M., and Tilley W.D. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. J Urol 157 6 (1997) 2323-2328
3. Joseph I.B., Nelson J.B., Denmeade S.R., and Isaacs J.T. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Clin Cancer Res 3 12 Pt 1 (1997) 2507-2511
4. Jain R.K., Safabakhsh N., Sckell A., et al. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc Natl Acad Sci USA 95 18 (1998) 10820-10825
5. Stefanou D., Batistatou A., Kamina S., Arkoumani E., Papachristou D.J., and Agnantis N.J. Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer. In Vivo 18 2 (2004) 155-160
6. Sinha A.A., Quast B.J., Reddy P.K., et al. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer. Exp Mol Pathol 77 2 (2004) 153-159
7. Bigler S.A., Deering R.E., and Brawer M.K. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 24 2 (1993) 220-226
8. Bettencourt M.C., Bauer J.J., Sesterhenn I.A., Connelly R.R., and Moul J.W. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy. J Urol 160 2 (1998) 459-465
9. Borre M., Offersen B.V., Nerstrom B., and Overgaard J. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 78 7 (1998) 940-944
10. Hall M.C., Troncoso P., Pollack A., et al. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Urology 44 6 (1994) 869-875
11. Rubin M.A., Buyyounouski M., Bagiella E., et al. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome. Urology 53 3 (1999) 542-547
12. Mirowitz S.A., Brown J.J., and Heiken J.P. Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging. Radiology 186 1 (1993) 153-157
13. Quinn S.F., Franzini D.A., Demlow T.A., et al. MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens. Radiology 190 2 (1994) 323-327
14. Brown G., Macvicar D.A., Ayton V., and Husband J.E. The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma. Clin Radiol 50 9 (1995) 601-606
15. Huch Boni R.A., Boner J.A., Lutolf U.M., Trinkler F., Pestalozzi D.M., and Krestin G.P. Contrast-enhanced endorectal coil MRI in local staging of prostate carcinoma. J Comput Assist Tomogr 19 2 (1995) 232-237
16. Daldrup H.E., Shames D.M., Husseini W., Wendland M.F., Okuhata Y., and Brasch R.C. Quantification of the extraction fraction for gadopentetate across breast cancer capillaries. Magn Reson Med 40 4 (1998) 537-543
17. Bruening R., Berchtenbreiter C., Holzknecht N., et al. Effects of three different doses of a bolus injection of gadodiamide: assessment of regional cerebral blood volume maps in a blinded reader study. AJNR Am J Neuroradiol 21 9 (2000) 1603-1610
18. Dennie J., Mandeville J.B., Boxerman J.L., Packard S.D., Rosen B.R., and Weisskoff R.M. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 40 6 (1998) 793-799
19. Collins D.J., and Padhani A.R. Dynamic magnetic resonance imaging of tumor perfusion Approaches and biomedical challenges. IEEE Eng Med Biol Mag 23 5 (2004) 65-83
20. Gibbs P., Young B.J., and Turnbull L. Diagnostic utility of perfusion weighted imaging of the prostate. Proceedings of the UK Radiological Congress. London (2001) 53
21. Noseworthy M.N., Morton G., and Wright GA. Comparison of normal and cancerous prostate using dynamic Tl and T2* weighted MRI. Proc Intl Soc Mag Reson Med 7 (2000) 2148
22. Hoskin P., Carnell D., Taylor N., et al. Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry. Int J Radiat Oncol Biol Phys 68 4 (2007) 1065-1071
23. Jager G.J., Ruijter E.T., van de Kaa C.A., et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 203 3 (1997) 645-652
24. Buckley D.L., Kerslake R.W., Blackband S.J., and Horsman A. Quantitative analysis of multi-slice Gd-DTPA enhanced dynamic MR images using an automated simplex minimization procedure. Magn Reson Med 32 5 (1994) 646-651
25. Donahue K.M., Burstein D., Manning W.J., and Gray M.L. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn Reson Med 32 1 (1994) 66-76
26. Padhani A.R., Khoo V.S., Suckling J., Husband J.E., Leach M.O., and Dearnaley D.P. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys 44 3 (1999) 525-533
27. Tofts P.S., Brix G., Buckley D.L., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10 3 (1999) 223-232
28. Tofts P.S. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 7 1 (1997) 91-101
29. Buckley D.L. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 47 3 (2002) 601-606
30. Trojan L., Thomas D., Friedrich D., et al. Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation. Anticancer Res 24 3a (2004) 1651-1656
31. Padhani A.R. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 16 4 (2002) 407-422
32. Engelbrecht M.R., Huisman H.J., Laheij R.J., et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229 1 (2003) 248-254
33. Padhani A.R., Gapinski C.J., Macvicar D.A., et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55 2 (2000) 99-109
34. Hara N., Okuizumi M., Koike H., Kawaguchi M., and Bilim V. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 62 2 (2005) 140-147
35. Kozlowski P., Chang S.D., Jones E.C., Berean K.W., Chen H., and Goldenberg S.L. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis-correlation with biopsy and histopathology. J Magn Reson Imaging 24 1 (2006) 108-113
36. Namimoto T., Morishita S., Saitoh R., Kudoh J., Yamashita Y., and Takahashi M. The value of dynamic MR imaging for hypointensity lesions of the peripheral zone of the prostate. Comput Med Imaging Graph 22 3 (1998) 239-245
37. Futterer J.J., Heijmink S.W., Scheenen T.W., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic Imaging. Radiology (2006)
38. Futterer J.J., Engelbrecht M.R., Huisman H.J., et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 237 2 (2005) 541-549
39. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 3 (2000) 551-560
40. van Lin E.N., Futterer J.J., Heijmink S.W., et al. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI. Int J Radiat Oncol Biol Phys 65 1 (2006) 291-303
41. Hayek O.R., Shabsigh A., Kaplan S.A., et al. Castration induces acute vasoconstriction of blood vessels in the rat prostate concomitant with a reduction of prostatic nitric oxide synthase activity. J Urol 162 4 (1999) 1527-1531
42. Shabsigh A., Chang D.T., Heitjan D.F., et al. Rapid reduction in blood flow to the rat ventral prostate gland after castration: preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival. Prostate 36 3 (1998) 201-206
43. Padhani A.R., MacVicar A.D., Gapinski C.J., et al. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology 218 2 (2001) 365-374
44. Alonzi R., Padhani A., Taylor N., et al. Functional MRI to investigate changes in oxygenation and vascularity of the prostate gland caused by androgen deprivation. Radiother. Oncol. 81 suppl. 1 (2006) s445 [abstract 1092]
45. Mandeville H., Ng Q., Milner J., et al. The effect of radiotherapy and combretastatin A-4 phosphate (CA4P) on prostate gland vascularity. Radiother Oncol 81 suppl. 1 (2006) s315
46. Harvey C.J., Blomley M.J., Dawson P., et al. Functional CT imaging of the acute hyperemic response to radiation therapy of the prostate gland: early experience. J Comput Assist Tomogr 25 1 (2001) 43-49
47. Huber P., Peschke P., Brix G., et al. Synergistic interaction of ultrasonic shock waves and hyperthermia in the Dunning prostate tumor R3327-AT1. Int J Cancer 82 1 (1999) 84-91
48. Takeda M., Akiba H., Yama N., Hareyama M., and Miyazaki T. Value of multi-sectional fast contrast-enhanced MR imaging in patients with elevated PSA levels after radical prostatectomy. Am J Roentgenol 178 suppl. (2002) s97
49. Rouviere O., Valette O., Grivolat S., et al. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor-correlation with biopsy findings. Urology 63 5 (2004) 922-927
50. Padhani A., Parker C., Norman A., Dearnley D., Leach M., and Husband J. Dynamic contrast enhanced MRI of prostate cancer for predicting patient outcome. Proc Intl Soc Mag Reson Med 10 (2002) 2094
51. d'Arcy J., Collins D., Padhani A., Walker-Samuel S., and Suckling J. Leach M: informatics in radiology (infoRAD): magnetic resonance imaging workbench: analysis and visualization of dynamic contrast-enhanced MR imaging data. Radiographics 26 2 (2006) 621-632